Related Materials - European Society of Cardiology

ESC/EACTS Page 7 of 34
revascularization. J Am Coll Cardiol 2006;47(4):871-877.
Serruys P. Two-year outcomes from the SYNTAX trial. 2009 Sep 21;
ESC Congress 2009 Sep 21; http://www.escardio.org/congresses/
esc-2009/congress-topic/Pages/Interventional-cardiology.aspx.
Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, Park
SW, Yun SC, Gwon HC, Jeong MH, Jang Y, Kim HS, Kim PJ, Seong
IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ. Stents
versus coronary-artery bypass grafting for left main coronary
artery disease. N Engl J Med 2008;358(17):1781-1792.
Taggart DP, Kaul S, Boden WE, Ferguson TB, Jr., Guyton RA, Mack
MJ, Sergeant PT, Shemin RJ, Smith PK, Yusuf S. Revascularization
for unprotected left main stem coronary artery stenosis stenting
or surgery. J Am Coll Cardiol 2008;51(9):885-892.
Valgimigli M, Malagutti P, Rodriguez-Granillo GA, Garcia-Garcia
HM, Polad J, Tsuchida K, Regar E, Van der Giessen WJ, de JP,
De FP, Serruys PW. Distal left main coronary disease is a major
predictor of outcome in patients undergoing percutaneous
intervention in the drug-eluting stent era: an integrated clinical
and angiographic analysis based on the Rapamycin-Eluting Stent
Evaluated At Rotterdam Cardiology Hospital (RESEARCH)
and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital
(T-SEARCH) registries. J Am Coll Cardiol 2006;47(8):1530-1537.
6.7 Recommendations
Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial
viability testing and impact of revascularization on prognosis
in patients with coronary artery disease and left ventricular
dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39(7):1151-
1158.
Bair TL, Muhlestein JB, May HT, Meredith KG, Horne BD,
Pearson RR, Li Q, Jensen KR, Anderson JL, Lappe DL. Surgical
revascularization is associated with improved long-term outcomes
compared with percutaneous stenting in most subgroups of
patients with multivessel coronary artery disease: results from
the Intermountain Heart Registry. Circulation 2007;116(11
Suppl):I226-I231.
Biondi-Zoccai GG, Lotrionte M, Moretti C, Meliga E, Agostoni
P, Valgimigli M, Migliorini A, Antoniucci D, Carrie D, Sangiorgi
G, Chieffo A, Colombo A, Price MJ, Teirstein PS, Christiansen
EH, Abbate A, Testa L, Gunn JP, Burzotta F, Laudito A, Trevi GP,
Sheiban I. A collaborative systematic review and meta-analysis
on 1278 patients undergoing percutaneous drug-eluting stenting
for unprotected left main coronary artery disease. Am Heart J
2008;155(2):274-283.
Bourque JM, Hasselblad V, Velazquez EJ, Borges-Neto S, O’connor
CM. Revascularization in patients with coronary artery disease,
left ventricular dysfunction, and viability: a meta-analysis. Am
Heart J 2003;146(4):621-627.
Buszman P, Szkrobka I, Gruszka A, Parma R, Tendera Z, Lesko B,
Wilczynski M, Bochenek T, Wojakowski W, Bochenek A, Tendera
M. Comparison of effectiveness of coronary artery bypass grafting
versus percutaneous coronary intervention in patients with
ischemic cardiomyopathy. Am J Cardiol 2007;99(1):36-41.
Buszman PE, Kiesz SR, Bochenek A, Peszek-Przybyla E, Szkrobka
I, Debinski M, Bialkowska B, Dudek D, Gruszka A, Zurakowski
A, Milewski K, Wilczynski M, Rzeszutko L, Buszman P, Szymszal
J, Martin JL, Tendera M. Acute and late outcomes of unprotected
left main stenting in comparison with surgical revascularization. J
Am Coll Cardiol 2008;51(5):538-545.
Califf RM, Armstrong PW, Carver JR, D’Agostino RB, Strauss WE.
27th Bethesda Conference: matching the intensity of risk factor
management with the hazard for coronary disease events. Task
Force 5. Stratification of patients into high, medium and low risk
subgroups for purposes of risk factor management. J Am Coll
Cardiol 1996;27(5):1007-1019.
Chieffo A, Park SJ, Valgimigli M, Kim YH, Daemen J, Sheiban I,
Truffa A, Montorfano M, Airoldi F, Sangiorgi G, Carlino M, Michev
I, Lee CW, Hong MK, Park SW, Moretti C, Bonizzoni E, Rogacka
R, Serruys PW, Colombo A. Favorable long-term outcome after
drug-eluting stent implantation in nonbifurcation lesions that
involve unprotected left main coronary artery: a multicenter
registry. Circulation 2007;116(2):158-162.
Fischer JJ, Samady H, McPherson JA, Sarembock IJ, Powers ER,
Gimple LW, Ragosta M. Comparison between visual assessment
and quantitative angiography versus fractional flow reserve for
native coronary narrowings of moderate severity. Am J Cardiol
2002;90(3):210-215.
Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J,
Brooks MM, Carrie D, Clayton TC, Danchin N, Flather M, Hamm
CW, Hueb WA, Kahler J, Kelsey SF, King SB, Kosinski AS, Lopes
N, McDonald KM, Rodriguez A, Serruys P, Sigwart U, Stables RH,
Owens DK, Pocock SJ. Coronary artery bypass surgery compared
with percutaneous coronary interventions for multivessel
disease: a collaborative analysis of individual patient data from ten
randomised trials. Lancet 2009;373(9670):1190-1197.
Kappetein AP, on behalf of the SYNTAX investigators. Optimal
revascularization strategy in patients with three-vessel disease and/
or left main disease.The 2-year Outcomes of the SYNTAX Trial.
ESC Congress 2009 Sep 21; http://www.escardio.org/congresses/
esc-2009/congress-topic/Pages/Interventional-cardiology.aspx.
Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R,
Brodie B, Hannan E, Harjai K, Jensen LO, Park SJ, Perry R, Racz M,
Saia F, Tu JV, Waksman R, Lansky AJ, Mehran R, Stone GW. Safety
and efficacy of drug-eluting and bare metal stents: comprehensive
meta-analysis of randomized trials and observational studies.
Circulation 2009;119(25):3198-3206.
Li Y, Zheng Z, Xu B, Zhang S, Li W, Gao R, Hu S. Comparison of
drug-eluting stents and coronary artery bypass surgery for the
treatment of multivessel coronary disease: three-year follow-up
results from a single institution. Circulation 2009;119(15):2040-
2050.
Naik H, White AJ, Chakravarty T, Forrester J, Fontana G, Kar S,
Shah PK, Weiss RE, Makkar R. A meta-analysis of 3,773 patients
treated with percutaneous coronary intervention or surgery for
unprotected left main coronary artery stenosis. JACC Cardiovasc
Interv 2009;2(8):739-747.
O’connor CM, Velazquez EJ, Gardner LH, Smith PK, Newman
MF, Landolfo KP, Lee KL, Califf RM, Jones RH. Comparison of
coronary artery bypass grafting versus medical therapy on longterm
outcome in patients with ischemic cardiomyopathy (a 25-year
experience from the Duke Cardiovascular Disease Databank). Am
J Cardiol 2002;90(2):101-107.
Palmerini T, Marzocchi A, Marrozzini C, Ortolani P, Saia F, Savini
C, Bacchi-Reggiani L, Gianstefani S, Virzi S, Manara F, Kiros WM,
Marinelli G, Di BR, Branzi A. Comparison between coronary
angioplasty and coronary artery bypass surgery for the treatment
of unprotected left main coronary artery stenosis (the Bologna
Registry). Am J Cardiol 2006;98(1):54-59.
Price MJ, Cristea E, Sawhney N, Kao JA, Moses JW, Leon MB, Costa
RA, Lansky AJ, Teirstein PS. Serial angiographic follow-up of
sirolimus-eluting stents for unprotected left main coronary artery
revascularization. J Am Coll Cardiol 2006;47(4):871-877.
Sedlis SP, Morrison DA, Lorin JD, Esposito R, Sethi G, Sacks J,
Henderson W, Grover F, Ramanathan KB, Weiman D, Saucedo
J, Antakli T, Paramesh V, Pett S, Vernon S, Birjiniuk V, Welt F,
Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D, Murphy
E, Ward H, Miller L, Kiesz S, Barbiere C, Lewis D. Percutaneous
coronary intervention versus coronary bypass graft surgery
for diabetic patients with unstable angina and risk factors for